BIOMAT Database Logo BIOMAT Database Logo

Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclampsia. 2000

Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
Department of Anesthesiology, University of Alabama at Birmingham, 35233-6810, USA. Yasser.Sakawi@ccc.uab.edu

BACKGROUND Recent evidence implicates nitric oxide (*NO) in the pathogenesis of preeclampsia. The authors tested the hypothesis that administration of low-dose endotoxin to pregnant rats mimics the signs of preeclampsia in humans and that *NO and *NO-derived species play a role in that animal model. METHODS Endotoxin was infused at doses of 1, 2 and 10 microg/kg over 1 h to rats on day 14 of pregnancy. Mean arterial pressure, urinary protein, urinary and plasma nitrite plus nitrate (NO2- + NO3-) concentrations, and platelet count were measured before and after the endotoxin infusion. In another group of pregnant rats, the nitric oxide synthase inhibitor L-nitroarginine methyl ester (L-NAME) was administered in drinking water at a dose of 3 mg x kg(-1) x d(-1) starting on day 7 of pregnancy. Endotoxin was then infused at 10 microg/kg on day 14 of pregnancy. Kidneys and uteroplacental units were examined histologically and analyzed immunohistochemically for 3-nitrotyrosine. RESULTS Endotoxin administration at doses of 2 and 10 microg/kg caused proteinuria and thrombocytopenia in pregnant rats, but did not result in hypertension. Urinary NO2- + NO3- concentration, reflective of tissue *NO production rates, was significantly elevated in pregnant rats that received endotoxin at 10 microg/kg. Ingestion of L-NAME caused hypertension. Tissues from pregnant rats treated with L-NAME, endotoxin at 10 microg/kg, and a combination of L-NAME and endotoxin had increased 3-nitrotyrosine immunoreactivity. CONCLUSIONS Nitric oxide either directly or through secondary species plays a significant role in the biochemical and physiologic changes that occur in a rodent model of endotoxin-induced injury.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats.
July 1994, American journal of obstetrics and gynecology,
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
Low-dose endotoxin infusion: a new model?
May 1995, American journal of obstetrics and gynecology,
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
Differential effects of low-dose endotoxin on the cerebral circulation during pregnancy.
December 2011, Reproductive sciences (Thousand Oaks, Calif.),
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
[Hypocalciuria during pregnancy as a risk factor of preeclampsia].
November 2004, Ginecologia y obstetricia de Mexico,
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
[Hyperhomocysteinemia during pregnancy as a risk factor of preeclampsia].
September 2003, Medicina clinica,
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
Low-dose aspirin during pregnancy.
August 1991, Lancet (London, England),
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
[Low dose of aspirin during pregnancy].
January 2007, Medicina clinica,
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
Regional blood flow during continuous low-dose endotoxin infusion.
January 1986, Circulatory shock,
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
Vitamin D Deficiency as a Risk Factor of Preeclampsia during Pregnancy.
November 2023, Diseases (Basel, Switzerland),
Y Sakawi, and M Tarpey, and Y F Chen, and D A Calhoun, and M G Connor, and D H Chestnut, and D A Parks
Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia.
January 2015, PloS one,
Copied contents to your clipboard!